Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02047214
Title Safety and Efficacy Study of TPI 287 + Avastin in Adults With Glioblastoma That Progressed Following Prior Avastin Therapy
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Cortice Biosciences, Inc.
Indications

glioblastoma

Therapies

Bevacizumab + Paclitaxel

Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
University of Alabama at Birmingham Birmingham Alabama 35249 United States Details
H Lee Moffitt Cancer Center and Research Institute, Inc. Tampa Florida 33612 United States Details
Northwestern Medical Faculty Foundation Chicago Illinois 60611 United States Details
Washington University, School of Medicine Saint Louis Missouri 63110 United States Details
Dartmouth-Hitchcock Medical Center Lebanon New Hampshire 03756 United States Details
John Theurer Cancer Center at Hackensack University Medical Center Hackensack New Jersey 07601 United States Details
University of Rochester Medical Center Rochester New York 14642 United States Details
The Ohio State University Wexner Medical Center Columbus Ohio 43210 United States Details
Memorial Hermann Hospital Houston Texas 77030 United States Details
University of Virginia Health System Charlottesville Virginia 22908 United States Details
Swedish Neuroscience Institute Seattle Washington 98122 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field